(Q78511683)

English

Vector-based delivery of tumor-associated antigens and T-cell co-stimulatory molecules in the induction of immune responses and anti-tumor immunity

scientific article published on 01 January 2002

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12430632%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference

Europe PubMed Central

Vector-based delivery of tumor-associated antigens and T-cell co-stimulatory molecules in the induction of immune responses and anti-tumor immunity (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12430632%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

3

object named as

Jeffrey Schlom

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12430632%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

author name string

James W Hodge

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12430632%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Douglas W Grosenbach

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12430632%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12430632%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Cancer Detection and Prevention

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12430632%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12430632%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12430632%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

275-291

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12430632%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Cancer vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunotherapy of cancer with dendritic-cell-based vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms and therapeutic applications of immune stimulatory cpG DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Nature, nurture and my experience with smallpox eradication.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Fowlpox virus host range restriction: gene expression, DNA replication, and morphogenesis in nonpermissive mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers. NIAID AIDS Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunisation with canarypox virus expressing rabies glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study in cancer patients of a replication-defective avipox recombinant vaccine that expresses human carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of colorectal carcinoma-associated antigens in colonic polyps

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Definition of the expression of the human carcinoembryonic antigen and non-specific cross-reacting antigen in human breast and lung carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative analysis of CEA expression in colorectal adenocarcinoma and serum: lack of correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of murine carcinoembryonic antigen gene family members

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Carcinoembryonic antigen-transgenic mice: a model for tumor immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of cytotoxic T cells and their antitumor activity in mice transgenic for carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced immune responses and anti-tumor activity by baculovirus recombinant carcinoembryonic antigen (CEA) in mice primed with the recombinant vaccinia CEA.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Diversified prime and boost protocols using recombinant vaccinia virus and recombinant non-replicating avian pox virus to enhance T-cell immunity and antitumor responses

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Compact, synthetic, vaccinia virus early/late promoter for protein expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA prime-canarypox boost with polycistronic hepatitis C virus (HCV) genes generates potent immune responses to HCV structural and nonstructural proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancing efficacy of recombinant anticancer vaccines with prime/boost regimens that use two different vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Costimulation of T cells for tumor immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

CD2 regulates responsiveness of activated T cells to interleukin 12.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The diversity of T-cell co-stimulation in the induction of antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

T cell co-stimulatory molecules other than CD28.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The cytoskeleton in lymphocyte signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

T cells: A proliferation of costimulatory molecules.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

CD2 stimulation leads to the delayed and prolonged activation of STAT1 in T cells but not NK cells

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of combination vaccinia vaccines and dual-gene vaccinia vaccines to enhance antigen-specific T-cell immunity via T-cell costimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic antitumor response after immunization with an admixture of recombinant vaccinia viruses expressing a modified MUC1 gene and the murine T-cell costimulatory molecule B7.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Construction and characterization of a recombinant vaccinia virus expressing murine intercellular adhesion molecule-1: induction and potentiation of antitumor responses

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-tumor immunity elicited by a recombinant vaccinia virus expressing CD70 (CD27L).

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of anti-tumor immunity elicited by tumor cells expressing a murine LFA-3 analog via a recombinant vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Human naive and memory T-helper cells display distinct adhesion properties to ICAM-1, LFA-3 and B7 molecules.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Dendritic cell development and maturation.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced activation of T cells by dendritic cells engineered to hyperexpress a triad of costimulatory molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Dendritic cells lose ability to present protein antigen after stimulating antigen-specific T cell responses, despite upregulation of MHC class II expression

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved efficacy of dendritic cell vaccines and successful immunization with tumor antigen peptide-pulsed peripheral blood mononuclear cells by coadministration of recombinant murine interleukin-12

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancing the potency of peptide-pulsed antigen presenting cells by vector-driven hyperexpression of a triad of costimulatory molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Vector-driven hyperexpression of a triad of costimulatory molecules confers enhanced T-cell stimulatory capacity to DC precursors

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and immune responses in resected colon cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Generation of Human Cytotoxic T Cells Specific for Human Carcinoembryonic Antigen Epitopes From Patients Immunized With Recombinant Vaccinia-CEA Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Dendritic cells pulsed with CEA peptide induce CEA-specific CTL with restricted TCR repertoire.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Construction and characterization of a triple-recombinant vaccinia virus encoding B7-1, interleukin 12, and a model tumor antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-10 enhances the therapeutic effectiveness of a recombinant poxvirus-based vaccine in an experimental murine tumor model

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor model

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Colon cancer cell vaccine prepared with replication-deficient vaccinia viruses encoding B7.1 and interleukin-2 induce antitumor response in syngeneic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer gene therapy using tumor cells infected with recombinant vaccinia virus expressing GM-CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Regional versus systemic delivery of recombinant vaccinia virus as suicide gene therapy for murine liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0361-090X%2802%2900095-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0361-090X(02)00095-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12430632%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12430632%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q78511683&oldid=1619820776"